Belden (BDC) Tops Q3 EPS by 7c, Posts Weak Q4 Guidance, Narrows FY11 Guidance
Get Alerts BDC Hot Sheet
Price: $122.28 --0%
Revenue Growth %: +37.7%
Financial Fact:
Gross profit: 245.96M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +37.7%
Financial Fact:
Gross profit: 245.96M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Belden (NYSE: BDC) reported Q3 EPS of $0.65, $0.07 better than the analyst estimate of $0.58. Revenue for the quarter came in at $519.7 million versus the consensus estimate of $508.51 million.
Belden sees FY2011 EPS of $2.33-$2.38, versus the consensus of $2.37. Belden sees FY2011 revenue of $2.01-$2.02 billion, versus the consensus of $2.02 billion.
Belden sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.62. Belden sees Q4 2011 revenue of $490-$500 million, versus the consensus of $517.44 million.
Belden sees FY2011 EPS of $2.33-$2.38, versus the consensus of $2.37. Belden sees FY2011 revenue of $2.01-$2.02 billion, versus the consensus of $2.02 billion.
Belden sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.62. Belden sees Q4 2011 revenue of $490-$500 million, versus the consensus of $517.44 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share